Supply
Providers, locations, service lines, clinicians, care models and geographic density.
Business intelligence
See the market beneath the medicine.
Market structure, pricing, ownership, service design and change over time for operators, investors, advisors and research teams working across private-pay health.
What the system measures
A shared evidence spine for commercial decisions.
Individual public records establish trust. Controlled business-intelligence products add scale, history, normalization and analysis.
Economics
Prices, inclusions, exclusions, membership design, pass-through costs and contract terms.
Infrastructure
Pharmacies, lab channels, Fullscript, Rupa, technology and fulfillment relationships.
Structure
Ownership, franchise systems, expansion, leadership and operating-model signals.
Change
Dated snapshots, pricing movement, offering changes and category development over time.
Demand
Thresholded, aggregate intent signals without licensing consumer-level transaction records.
Reporting and delivery
From a market question to a usable answer.
The public site remains useful by the page. Bulk access, longitudinal analysis and machine delivery stay controlled.
Briefs and dashboards
- Market and category maps
- Pricing and offering benchmarks
- Ownership and expansion signals
- Coverage and methodology notes
Exports and feeds
- Current controlled snapshots
- Historical and change datasets
- CSV, XLSX and CRM-ready delivery
- Field-level provenance
API and MCP
- Authenticated queries
- Entitled fields by customer
- Dated answers with source context
- No public browser payload of the full dataset
Custom intelligence
- Commercial diligence
- Market-entry research
- Competitor and channel mapping
- Ongoing monitoring
The trust boundary
Intelligence cannot buy influence.
Data access does not purchase placement, ranking, a badge, favorable coverage or changes to the public record. Provider-submitted evidence is labeled and reviewed independently.
Confidential pricing, identifiable consumer contributions and licensed-restricted source material remain outside public and ordinary client delivery.
Request access
Start with the decision—not a data dump.
Tell us the market, geography and question. We’ll identify the appropriate coverage, delivery format and evidence standard.
Peptide supply-chain evidence
Explore 648 dated regulatory records with source links and matching limitations.
Explore the evidence